Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)
This study is ongoing, but not recruiting participants.
Sponsor:
Spectrum Pharmaceuticals, Inc
Collaborator:
TopoTarget A/S
Information provided by (Responsible Party):
Spectrum Pharmaceuticals, Inc
ClinicalTrials.gov Identifier:
NCT00865969
First received: March 19, 2009
Last updated: May 8, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | September 2013 |
| Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |